Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-31 5:04 pm Purchase | 2024-10-17 | 13G | INVENTIVA SA ADR IVA | Invus Public Equities, L.P. | 7,407,406 7.800% | 7,407,406 (New Position) | Filing History |
| 2025-03-26 4:56 pm Purchase | 2024-12-13 | 13G | INVENTIVA SA ADR IVA | PERCEPTIVE ADVISORS LLC | 5,555,555 5.800% | 5,555,555 (New Position) | Filing History |
| 2025-02-14 4:20 pm Purchase | 2024-12-31 | 13G | INVENTIVA SA ADR IVA | Sofinnova Crossover I SLP | 7,792,307 7.200% | 1,681,480 (+27.52%) | Filing History |
| 2025-02-14 4:05 pm Purchase | 2024-12-31 | 13G | INVENTIVA SA ADR IVA | Pierre Broqua | 4,097,500 4.300% | 215,000 (+5.54%) | Filing History |
| 2024-12-23 9:25 pm Unchanged | 2024-12-19 | 13D | INVENTIVA SA ADR IVA | BIOTECHNOLOGY VALUE FUND L P | 8,545,499 9.000% | 0 (Unchanged) | Filing History |
| 2024-11-13 12:26 pm Purchase | 2024-09-30 | 13G | INVENTIVA SA ADR IVA | Yiheng Capital Management L.P. | 4,331,196 8.310% | 1,686,270 (+63.75%) | Filing History |
| 2024-10-21 9:00 pm Unchanged | 2024-10-17 | 13D | INVENTIVA SA ADR IVA | BIOTECHNOLOGY VALUE FUND L P | 8,545,499 9.800% | 0 (Unchanged) | Filing History |
| 2024-10-21 8:54 pm Purchase | 2024-10-17 | 13D | INVENTIVA SA ADR IVA | New Enterprise Associates 17, L.P. | 7,835,884 9.000% | 2,262,931 (+40.61%) | Filing History |
| 2024-07-19 4:30 pm Unchanged | 2024-07-17 | 13D | INVENTIVA SA ADR IVA | BIOTECHNOLOGY VALUE FUND L P | 8,545,499 16.300% | 0 (Unchanged) | Filing History |
| 2024-05-03 9:22 pm Purchase | 2024-04-03 | 13D | INVENTIVA SA ADR IVA | New Enterprise Associates 17, L.P. | 5,572,953 10.700% | 420,920 (+8.17%) | Filing History |
| 2024-02-14 4:08 pm Unchanged | 2023-12-31 | 13G | INVENTIVA SA ADR IVA | Yiheng Capital Management L.P. | 2,644,926 6.280% | 0 (Unchanged) | Filing History |
| 2024-02-09 4:49 pm Purchase | 2023-12-31 | 13G | INVENTIVA SA ADR IVA | Sofinnova Crossover I SLP | 6,110,827 9.700% | 2,728,888 (+80.69%) | Filing History |
| 2023-09-25 4:35 pm Purchase | 2023-08-31 | 13D | INVENTIVA SA ADR IVA | BIOTECHNOLOGY VALUE FUND L P | 8,545,499 16.500% | 587,361 (+7.38%) | Filing History |
| 2023-09-05 4:58 pm Purchase | 2023-08-30 | 13G | INVENTIVA SA ADR IVA | Qatar Investment Authority | 5,157,233 9.970% | 5,157,233 (New Position) | Filing History |
| 2023-02-14 4:08 pm Purchase | 2022-12-31 | 13G | INVENTIVA SA ADR IVA | Yiheng Capital Management L.P. | 2,644,926 6.470% | 2,644,926 (New Position) | Filing History |
| 2023-02-13 2:07 pm Purchase | 2022-12-31 | 13G | INVENTIVA SA ADR IVA | Sofinnova Crossover I SLP | 3,381,939 8.000% | 129,032 (+3.97%) | Filing History |
| 2022-02-11 12:00 pm Purchase | 2021-12-31 | 13G | INVENTIVA SA ADR IVA | Sofinnova Crossover I SLP | 3,252,907 6.200% | 138,880 (+4.46%) | Filing History |